Pathology Inc

pathologyinc.com

Pathology, Inc. is the West Coast's premier Women's Health laboratory, with subspecialty expertise in anatomic, molecular and digital pathology. Our integrated diagnostic services help doctors personalize patient care to optimally treat disease and maintain health and wellness. We are committed to providing only the highest level of testing quality and service and working with you to provide unique solutions to your most challenging needs.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

FIERCEPHARMAPOLITICS—GILEAD CEO SEES COVID-19 CHANGING THE DRUG PRICING CONVERSATION

Fiercepharma | May 04, 2020

news image

Welcome to the FiercePharma political roundup, where each Monday we’ll highlight developments in Washington, D.C., and elsewhere that could affect drug pricing and how drugmakers operate. With less than six months to go until the U.S. elections, the pharma industry finds itself in a different position than expected at the start of the year. While many predicted a tense year as candidates went on the attack, the pandemic has taken the spotlight. And instead of being an easy target, pharma c...

Read More

Business Insights

BIOCYTOGEN EXPANDS PARTNERSHIP WITH MERCK KGAA, DARMSTADT, GERMANY

Biocytogen and Merck KGaA, Darmstadt, Germany | August 26, 2022

news image

Biocytogen Pharmaceuticals Co., Ltd. entered into a global licensing agreement with Merck KGaA, Darmstadt, Germany, for the use of Biocytogen’s RenMiceTM platform. Under the terms of the agreement, Merck KGaA, Darmstadt, Germany will have full access to Biocytogen’s RenMiceTM platform to discover and develop fully human antibody therapeutics for an unlimited number of drug targets. Merck KGaA, Darmstadt, Germany will be responsible for all clinical development, manufacturing, and com...

Read More

Pharmacy Market

CASCADE CHEMISTRY INITIATES $14 MILLION EXPANSION OF CGMP PHARMACEUTICAL MANUFACTURING CAPACITY

Cascade Chemistry | February 19, 2021

news image

Cascade Chemistry, a main pharmaceutical contract development and manufacturing organization, today declared inception of development of new offices intended to expand the organization's ability to manufacture APIs (dynamic pharmaceutical ingredients) under cGMP (current Good Manufacturing Practices standards and procedures). The new offices, expected to be operational in the main quarter of 2022, will eventually expand the organization's floor space just about three-overl...

Read More

Pharma Tech

IACTA PHARMACEUTICALS AND TALLC CORPORATION ANNOUNCE STRATEGIC COLLABORATION TO UTILIZE NOVEL SMARTCELLE TOPICAL DELIVERY TECHNOLOGY

IACTA Pharmaceuticals, Inc. | December 16, 2021

news image

IACTA Pharmaceuticals, Inc. an innovation leader in ophthalmic therapeutics, and TALLC Corporation Inc. a pioneering ophthalmology company focused on the growing unmet needs of patients with corneal and retinal conditions, announced that they are entering into a strategic collaboration and licensing agreement. The agreement grants IACTA the use of TALLC’s proprietary SmartCelle™ micellar technology, a novel platform for pan-ocular drug delivery, for future clinical development. IACTA...

Read More
news image

FIERCEPHARMAPOLITICS—GILEAD CEO SEES COVID-19 CHANGING THE DRUG PRICING CONVERSATION

Fiercepharma | May 04, 2020

Welcome to the FiercePharma political roundup, where each Monday we’ll highlight developments in Washington, D.C., and elsewhere that could affect drug pricing and how drugmakers operate. With less than six months to go until the U.S. elections, the pharma industry finds itself in a different position than expected at the start of the year. While many predicted a tense year as candidates went on the attack, the pandemic has taken the spotlight. And instead of being an easy target, pharma c...

Read More
news image

Business Insights

BIOCYTOGEN EXPANDS PARTNERSHIP WITH MERCK KGAA, DARMSTADT, GERMANY

Biocytogen and Merck KGaA, Darmstadt, Germany | August 26, 2022

Biocytogen Pharmaceuticals Co., Ltd. entered into a global licensing agreement with Merck KGaA, Darmstadt, Germany, for the use of Biocytogen’s RenMiceTM platform. Under the terms of the agreement, Merck KGaA, Darmstadt, Germany will have full access to Biocytogen’s RenMiceTM platform to discover and develop fully human antibody therapeutics for an unlimited number of drug targets. Merck KGaA, Darmstadt, Germany will be responsible for all clinical development, manufacturing, and com...

Read More
news image

Pharmacy Market

CASCADE CHEMISTRY INITIATES $14 MILLION EXPANSION OF CGMP PHARMACEUTICAL MANUFACTURING CAPACITY

Cascade Chemistry | February 19, 2021

Cascade Chemistry, a main pharmaceutical contract development and manufacturing organization, today declared inception of development of new offices intended to expand the organization's ability to manufacture APIs (dynamic pharmaceutical ingredients) under cGMP (current Good Manufacturing Practices standards and procedures). The new offices, expected to be operational in the main quarter of 2022, will eventually expand the organization's floor space just about three-overl...

Read More
news image

Pharma Tech

IACTA PHARMACEUTICALS AND TALLC CORPORATION ANNOUNCE STRATEGIC COLLABORATION TO UTILIZE NOVEL SMARTCELLE TOPICAL DELIVERY TECHNOLOGY

IACTA Pharmaceuticals, Inc. | December 16, 2021

IACTA Pharmaceuticals, Inc. an innovation leader in ophthalmic therapeutics, and TALLC Corporation Inc. a pioneering ophthalmology company focused on the growing unmet needs of patients with corneal and retinal conditions, announced that they are entering into a strategic collaboration and licensing agreement. The agreement grants IACTA the use of TALLC’s proprietary SmartCelle™ micellar technology, a novel platform for pan-ocular drug delivery, for future clinical development. IACTA...

Read More